Clinical trial
The Impact of Early Diagnosis and Treatment of Obstructive Sleep Apnea on Hospital Readmission in Hospitalized Cardiac Patients: the CV Readmit Clinical Trial
NCT03647891 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Impact of Early Diagnosis and Treatment of Obstructive Sleep Apnea on Hospital Readmission in Hospitalized Cardiac Patients: the CV Readmit Clinical Trial
- Lead sponsor
- Kaiser Permanente
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- July 31, 2017
- Completion date
- September 11, 2017
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
arrhythmia, cardiac, heart failure, myocardial infarction, osa